HALEON

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 1 drug with upcoming expirations

Activity

Recent Activity

Last 14 days

Jul 2, 2026

Completed

A Phase I, Randomised, Open Label, Single Center, Single Oral Dose, Three Treatment, Three Period, Three Sequence, Change-over Bioequivalence Study of Paracetamol Orodispersible Tablet 500 mg (Haleon) to Assess Bioequivalence With Alvedon 500 mg Film-Coated Tablet (Haleon, Sweden) and Panadol 500 mg Film-Coated Tablet (Haleon, Australia) in Healthy Adult Subjects Under Fasting Conditions

Jul 1, 2026

Recruiting

A Phase I, Single-Center, Open-Label, Single-Dose, Pharmacokinetic Study to Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml in an Oral Liquid Suspension Fixed-Dose Combination Product in Children Aged 6 to 11 Years

Earlier

Jan 16, 2026TrialA Clinical Study to Evaluate the Effectiveness of an Test Toothpaste for the Relief of Dentin Hypersensitivity in a Chinese Population

Dec 17, 2025TrialA Bioequivalence Study of Advil Tablet (Mini) (Ibuprofen 200 mg) Versus Advil Tablet (Ibuprofen 200 mg) in Healthy Adult Subjects Under Fasted Conditions and Bioavailability Assessment of Advil Tablet (Mini) Under Fed Conditions

Dec 15, 2025TrialA Study to Investigate the Tooth Whitening and Dentin Hypersensitivity Effectiveness of Two Experimental Toothpastes

Nov 19, 2025TrialA Clinical Study to Evaluate the Effectiveness of an Experimental Toothpaste in Improving Gum Health and Reducing Plaque Accumulation

Oct 27, 2025TrialA Study to Evaluate the Effect of a Test (Sodium Bicarbonate) Toothpaste on the Oral Microbiome

Sep 16, 2025TrialClinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice

4 more events

Sep 9, 2025TrialA Clinical Study Investigating the Efficacy of an Experimental Toothpaste Containing Stannous Fluoride in Improving Gingival Health

Aug 20, 2025TrialA Clinical Study to Assess the Effectiveness of ENO Lime in Participants With Ajeerna Vyadhi (Acidity, Acid Indigestion, Indigestion, and Associated Nausea)

Apr 28, 2025TrialA Clinical Study to Assess an Experimental Dentifrice in an Experimental Model of Early Stage Caries

Apr 21, 2025TrialA Clinical Study to Evaluate the Efficacy of a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

2 patent groups across drugs · Source: FDA Orange Book

DrugExpires

NicoretteApr 30, 2028 Nicorette2 patentsApr 30, 2029

Regulatory

Regulatory Timeline

19821 event

FDAJan 1

Tavist — TAVIST

Application NDA017661 (NDA)

19851 event

FDAJun 28

Tavist — TAVIST

Application NDA018675 (NDA)

19881 event

FDAApr 12

Axid — AXID

Application NDA019508 (NDA)

19921 event

FDAAug 21

Tavist — TAVIST-1

Application NDA020925 (NDA)

19965 events

FDAMay 9

Axid — AXID AR

Application NDA020555 (NDA)

FDAFeb 9

Nicorette — NICORETTE

Application NDA020066 (NDA)

FDAFeb 9

Nicorette — NICORETTE

Application NDA018612 (NDA)

FDAFeb 9

Nicorette — NICORETTE

Application NDA018612 (NDA)

FDAFeb 9

Nicorette — NICORETTE

Application NDA020066 (NDA)

20001 event

FDAJul 25

Abreva — ABREVA

Application NDA020941 (NDA)

20022 events

FDAOct 31

Nicorette — NICORETTE

Application NDA021330 (NDA)

FDAOct 31

Nicorette — NICORETTE

Application NDA021330 (NDA)

20041 event

FDAMay 25

Axid — AXID

Application NDA021494 (NDA)

20092 events

FDAMay 18

Nicorette — NICORETTE

Application NDA022360 (NDA)

FDAMay 18

Nicorette — NICORETTE

Application NDA022360 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)